Kissei Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kissei Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kissei Pharmaceutical Co Ltd Strategy Report
- Understand Kissei Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Kissei Pharmaceutical Catalyst Calendar
Proactively evaluate Kissei Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Kissei Pharmaceutical Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Jun 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Mar 2020 | Phase II Trial Completion | Kissei Pharmaceutical Co Ltd; Maruishi Pharmaceutical Co Ltd | 4547 | difelikefalin | Dermatology; Genito Urinary System And Sex Hormones | Chronic Kidney Disease (Chronic Renal Failure); Pruritus; Uremic (Renal) Pruritus | Clinical Trial Registry |
| 29 Jan 2020 | Drug Expiry (EU) | Kissei Pharmaceutical Co Ltd | 4547 | silodosin | Genito Urinary System And Sex Hormones; Male Health | Dysuria; Storage Symptoms of Benign Prostatic Hyperplasia; Voiding Symptoms of Benign Prostatic Hyperplasia | GD Estimates |
| 31 Dec 2019 | Phase I Trial Completion | EA Pharma Co Ltd; Kissei Pharmaceutical Co Ltd | 4547 | carotegrast methyl | Gastrointestinal | Ulcerative Colitis | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer